Network origin in Duncan McGregor first degree
Entity | Entity type | Industry | |
---|---|---|---|
Enkefalos Biosciences, Inc.
Enkefalos Biosciences, Inc. BiotechnologyHealth Technology Enkefalos Biosciences, Inc. provides biotechnology services. The CEO of the American company is Duncan McGregor.
2
| Holding Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Duncan McGregor via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
Hiram College | College/University | Undergraduate Degree | |
Fabrus, Inc.
Fabrus, Inc. BiotechnologyHealth Technology Fabrus, Inc. engages in discovering, developing and engineering therapeutic antibodies. It utilizes multiple proprietary product engines that define a new antibody discovery paradigm. The company is headquartered in San Diego, CA. | Biotechnology | Founder | |
Stanford University School of Medicine | College/University | Doctorate Degree | |
Elizabeth Smider Foundation | Founder | ||
Integrigen, Inc. | Chief Tech/Sci/R&D Officer | ||
Minotaur Therapeutics, Inc.
Minotaur Therapeutics, Inc. BiotechnologyHealth Technology Minotaur Therapeutics is a private biotechnology company that specializes in developing unique biotherapeutics for oncology and immunology. The company is based in San Diego, CA. The company uses the novel ultralong cdr h3 scaffold of bovine antibodies to achieve unique targeting properties. Minotaur has licensing and partnership arrangements with the Applied Biomedical Science Institute and OmniAb on this emerging therapeutic class and its underlying technologies. The CEO of the company is Vaughn V. Smider. | Biotechnology | Chief Executive Officer |
Statistics
International
United States | 9 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Operational
Director/Board Member | 6 |
Chief Executive Officer | 3 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 2 |
President | 1 |
Most connected contacts
Insiders | |
---|---|
Vaughn V. Smider | 9 |
Wei Zhao | 1 |
- Stock Market
- Insiders
- Duncan McGregor
- Company connections